A benchmark for dose finding studies with continuous outcomes-Reference-Cited by-同舟云学术

A benchmark for dose finding studies with continuous outcomes

Published:2018-08-24 Issue: Volume: Page:
ISSN:1465-4644
Container-title:Biostatistics
language:en
Short-container-title:

Author:

Mozgunov Pavel¹,Jaki Thomas¹,Paoletti Xavier²

Affiliation:

1. Department of Mathematics and Statistics, Lancaster University, Bailrigg, Lancaster LA1 4YF, UK

2. Service de Biostatistique et d’Epidémiologie & CESP OncoStat, INSERM, Institut Gustave Roussy, Université Paris-11, 114, Rue Edouard Vaillant, Villejuif, France

Funder

European Union's Horizon 2020

Institut National du Cancer

National Institute for Health Research

Department of Health

Publisher

Oxford University Press (OUP)

Subject

Statistics, Probability and Uncertainty,General Medicine,Statistics and Probability

Link

http://academic.oup.com/biostatistics/advance-article-pdf/doi/10.1093/biostatistics/kxy045/25543751/kxy045.pdf

Reference16 articles.

1. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial;Bekele,;Biometrics,2005

2. Simple benchmark for complex dose finding studies;Cheung,;Biometrics,2014

3. Phase I trial of o6-benzylguanine for patients undergoing surgery for malignant glioma;Friedman,;Journal of Clinical Oncology,1998

4. An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trials;Hirakawa,;Statistics in Medicine,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of model-free phase I dose escalation designs for dual-agent combination therapies;Statistical Methods in Medical Research;2024-01-24

2. Application of multi-armed bandits to dose-finding clinical designs;Artificial Intelligence in Medicine;2023-12

3. Data-dependent contrast test for dose-finding clinical trials;Contemporary Clinical Trials;2023-08

4. Rejoinder: Response-Adaptive Randomization in Clinical Trials;Statistical Science;2023-05-01

5. CFO: Calibration-free odds design for phase I/II clinical trials;Statistical Methods in Medical Research;2022-03-03